United Health Products, Inc. is a medical technology and device company focused on improving patient outcomes and reducing health care costs across the surgical, dialysis, dental, and emergency medicine sectors through products that control bleeding. We manufacture and distribute our patented hemostatic gauze, HemoStyp®, which is derived from natural cellulose found in plant material. HemoStyp® is a neutral pH Regenerated Cellulose designed to absorb exudate/drainage from wounds to help control bleeding.

Improving patient outcomes and
reducing health care costs.

Our Mission

The hemostatic performance, benign impact on patient tissue, and ease of use of our HemoStyp® technology offer medical practitioners an unmatched value proposition. UHP is currently pursuing a class III PMA internal surgical use in topical applications, dental procedures, and veterinary surgeries. The application to the FDA for Premarket Approval (“PMA”) of our hemostatic gauze as a Class III medical device that would allow the gauze to be used for internal bleeding during human surgical procedures was submitted March 21, 2024 and is currently under review by the FDA.

American Made

We manufacture our HemoStyp product in America in collaboration with contract manufacturing partners. Starting with standard cotton and using our proprietary process that involves a series of carefully controlled steps, we generate our Neutralized Regenerated Cellulose, which is then cut to specified dimensions and packaged as the full range of HemoStyp® products. Once packaging is complete it travels to an FDA approved, government authorized gamma radiation sterilization facility to ensure the product is sterile and in compliance with applicable regulations.